menu ☰
menu ˟

Ocuphire completes financing round for advancement of Nyxol

22 Jul 2019
Ocuphire Pharma has closed $5 million in financing to support multiple phase 2 trials of Nyxol, its lead drug candidate, according to a press release.Nyxol, an ophthalmic solution eye drop containing phentolamine mesylate and designed to treat front-...

Click here to view the full article which appeared in Opthalmology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.